Authors


Roche

Latest:

UNCOVERING HIDDEN PREDATORS IN DISEASE

This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.


Dr Marco Mura

Latest:

Maintaining quality and safety in retina clinics during a pandemic

To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.


Cynthia Matossian; Special to Ophthalmology Times®

Latest:

Cataract predictability: Screen and treat unstable tear film in weeks

Correcting abnormal tear film osmolarity before cataract surgery enables more accurate measurements to be captured, reducing residual refractive error.


Jean-Francois Korobelnik, MD

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.



Dr Clara C. Chan

Latest:

What innovation means for the treatment of corneal dystrophies

Physician outlines latest emerging technologies to treat condition


Brian Shafer, MD

Latest:

Fortified antibiotic advance improves corneal infection treatment paradigm

No two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence


Dr Gustavo De Moraes

Latest:

Tried and tested therapeutic options for meibomian gland dysfunction

Methods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.


Dr Ahmed Harmouche

Latest:

Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.


C. Ellis Wisely, MD, MBA

Latest:

Retinal imaging to detect Alzheimer disease: machine learning model

An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.


Dr John Vukich

Latest:

No toric? No problem: Small-aperture optics can mitigate astigmatism

A one-piece, hydrophobic, monofocal IOL uses the small-aperture concept to provide a good alternative to the toric IOLs currently available.


Cheryl Guttman Krader; Reviewed by Dr Antonio M. Fea

Latest:

Study examines pairing phacoemulsification with implantation of stents

A cost-utility analysis found that concurrent phacoemulsification and minimally invasive glaucoma surgery using trabecular microbypass stents is cost-effective for treating mild to moderate open-angle glaucoma, compared with cataract surgery alone.



Renato Ambrósio Jr, MD, PhD

Latest:

Artificial intelligence for the early detection of ectatic corneal diseases

One of AI’s most promising applications: new diagnostic algorithms


Sharon Fekrat, MD, FASRS

Latest:

Retinal imaging to detect Alzheimer disease: machine learning model

An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.


Dr Szilárd Kiss

Latest:

Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment safer

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.





Prof. Bora M Eldem

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Dr Ben LaHood
Dr Ben LaHood

Latest:

Toric IOLs for beginners: What to consider before and during surgery and in the postoperative period

Giving due consideration to preoperative marking and the surgical technique in toric IOL implantation, as well as being diligent about reviewing postoperative results, can improve patient outcomes whilst minimising the chance of errors.


Dr Sachiko Kaidzu

Latest:

Leveraging UVC light for infection prevention in ophthalmology and beyond

The threshold limit value is increased for virus and bacterial eradication.


Francesc March de Ribot, MD, PhD, FEBO

Latest:

Considering cataract surgery and reduction of dementia in Europe

The procedure facilitates an independent life, better care and fewer costs.


Lynda Charters; Reviewed by Dr A. John Kanellopoulos

Latest:

AI enhances customised myopic LASIK with ray tracing optimisation

Customised myopic LASIK using automated ray tracing optimisation has the potential to offer improved and more predictable outcomes, a study shows.


Prof. Achim Langenbucher

Latest:

The 30-year history of optical coherence tomography of the human eye

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Cheryl Guttman Krader; Reviewed by Dr Albert J. Augustin

Latest:

DMO study shows robust efficacy of intravitreal dexamethasone implant

In a real-world study of patients with treatment-naïve and previously treated diabetic macular oedema, injection of intravitreal dexamethasone 0.7-mg implant provided effective disease control with initial and repeat injections, regardless of reinjection interval.


Jennifer Lim, MD, FARVO, FASRS

Latest:

Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DME

Dr Jennifer Lim presents two case studies demonstrating the application of the personalized treatment interval algorithm from the YOSEMITE and RHINE clinical trials for faricimab in DME.


Hattie Hayes; Reviewed by Sheng Lim, MD

Latest:

New MIGS devices aid patients and test patience

In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices


Louise Veenhuis

Latest:

ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World Leaders

OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.


Alper Bilgic, MD, FEBO

Latest:

Considering cataract surgery and reduction of dementia in Europe

The procedure facilitates an independent life, better care and fewer costs.

© 2024 MJH Life Sciences

All rights reserved.